S 8510

Known as: S-8510 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-1998
012319961998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The present study investigated the effects of a novel benzodiazepine inverse agonist, S-8510 [2-(3-isoxazolyl)-3, 6, 7, 9… (More)
  • figure 2
  • figure 1
  • table 1
  • table 2
  • figure 3
Is this relevant?
1999
1999
A radioimmunoassay (RIA) was developed for a new benzodiazepine inverse agonist, 2-(isoxazol-3-yl)-3,6,7,9-tetrahydroimidazo [4,5… (More)
Is this relevant?
1999
1999
The permeability surface area (PS) product, an index of permeability of the blood-brain barrier (BBB), was measured by using the… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
1998
1998
We investigated the effects of a novel benzodiazepine partial inverse agonist, S-8510 (2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo… (More)
Is this relevant?
1998
1998
Enhancing the release of acetylcholine (ACh) in the brain is one approach to increasing neuronal activity, restoring central… (More)
Is this relevant?
1998
1998
1. The pharmacokinetics of a novel benzodiazepine partial inverse agonist (S-8510) were studied in the Fischer 344 (F344) rat and… (More)
Is this relevant?
1996
1996
1. Pharmacological actions of a novel benzodiazepine receptor ligand, S-8510 (2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo[4,5-d… (More)
Is this relevant?
1996
1996
2-Arylimidazo[4,5-c]quinolines and analogous fused imidazopyridines were synthesized and evaluated as benzodiazepine receptor… (More)
Is this relevant?